Bristol-Myers Squibb BMY Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $7.27B+35.6% | $7.06B+178% | $5.97B+182% | $4.99B+176% | $5.36B+187% | ||
| $3.59B-55.5% | $4.01B-58.2% | $4.91B-51.7% | $6.5B-35.2% | $8.08B-18.1% | ||
| $555M+7.1% | $553M+9.1% | $540M+5.1% | $530M+2.5% | $518M-2.1% | ||
| $13.31B-7.0% | $14.16B-6.8% | $16.62B+10.8% | $15.9B+12.3% | $14.31B+4.3% | ||
| $1.4B+14.2% | $1.31B+5.0% | $1.32B+9.9% | $1.32B+8.6% | $1.22B+0.7% | ||
| $3.93B+113% | $3.94B-81.9% | $2.28B-89.8% | $758M-96.6% | $1.85B-91.3% | ||
| -$3.76B-68.6% | -$4.13B+80.6% | -$2.87B+87.2% | -$1.39B+93.9% | -$2.23B+89.7% | ||
| $5.07B+3.3% | $5.05B+3.7% | $5B+4.1% | $4.95B+3.6% | $4.91B+3.1% | ||
| $11.44B+298% | $10.94B+281% | $872M-82.1% | $3.12B+30.3% | $2.87B+28.3% | ||
| -$10.92B— | -$10.35B— | —— | —— | —— | ||
| -$1.29B— | -$129M— | —— | —— | —— | ||
| $11.91B-9.0% | $12.85B-7.9% | $15.3B+10.9% | $14.58B+12.6% | $13.09B+4.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Bristol-Myers Squibb generate?
- Bristol-Myers Squibb (BMY) generated $13.3B in operating cash flow over the trailing twelve months.
- What is Bristol-Myers Squibb's free cash flow?
- After $1.4B of capital expenditures, Bristol-Myers Squibb's free cash flow was $11.9B over the trailing twelve months, down 9.0% year over year.
- Where does Bristol-Myers Squibb's cash flow data come from?
- Every line is extracted from Bristol-Myers Squibb's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
